General Clinical Study of AJG555 in Pediatric Patients with Chronic Constipation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223327

Enrollment

Registered

2016-10-25

Start date

2016-10-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic constipation

Interventions

investigational material(s) Generic name etc : MOVICOL (AJG555) INN of investigational material : Macrogol 4000 Therapeutic category code : 235 Purgatives and clysters Dosage and Administration for In

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients with chronic constipation

Exclusion criteria

Exclusion criteria: - Patients with organic constipation or patients suspected of having organic constipation - Patients with symptomatic constipation or patients suspected of having symptomatic constipation - Patients with drug-induced constipation or patients suspected of having drug-induced constipation

Design outcomes

Primary

Measure	Time frame
efficacy Frequency of Spontaneous Bowel Movement(SBM) Change from baseline	—

Secondary

Measure	Time frame
efficacy safety - Complete Spontaneous Bowel Movement (CSBM) - SBM and CSBM Responder Rate - Number of Dates to the First SBM and First CSBM - Use of Rescue Medication - Stool Consistency Measured by Bristol Stool Form Scale	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026